4-Hydroxybutyric Acid
The risk or severity of adverse effects can be increased when Gamma Hydroxybutyric Acid is combined with Ramelteon.
Abiraterone
The serum concentration of Ramelteon can be increased when it is combined with Abiraterone.
Acepromazine
The risk or severity of adverse effects can be increased when Ramelteon is combined with Acepromazine.
Advertisement
Aceprometazine
The risk or severity of adverse effects can be increased when Ramelteon is combined with Aceprometazine.
Acetyl Sulfisoxazole
The serum concentration of Ramelteon can be increased when it is combined with Acetyl sulfisoxazole.
Alfaxalone
The risk or severity of adverse effects can be increased when Ramelteon is combined with Alfaxalone.
Advertisement
Alfentanil
The risk or severity of adverse effects can be increased when Alfentanil is combined with Ramelteon.
Alphaprodine
The risk or severity of adverse effects can be increased when Ramelteon is combined with Alphaprodine.
Alprazolam
The risk or severity of adverse effects can be increased when Alprazolam is combined with Ramelteon.
Advertisement
Amiodarone
The serum concentration of Ramelteon can be increased when it is combined with Amiodarone.
Amisulpride
The risk or severity of adverse effects can be increased when Ramelteon is combined with Amisulpride.
Amitriptyline
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Ramelteon.
Amobarbital
The risk or severity of adverse effects can be increased when Amobarbital is combined with Ramelteon.
Amoxapine
The risk or severity of adverse effects can be increased when Amoxapine is combined with Ramelteon.
Apalutamide
The serum concentration of Ramelteon can be decreased when it is combined with Apalutamide.
Aprepitant
The serum concentration of Ramelteon can be increased when it is combined with Aprepitant.
Aripiprazole
The risk or severity of adverse effects can be increased when Aripiprazole is combined with Ramelteon.
Armodafinil
The metabolism of Ramelteon can be decreased when combined with Armodafinil.
Articaine
The risk or severity of adverse effects can be increased when Ramelteon is combined with Articaine.
Asenapine
The risk or severity of adverse effects can be increased when Asenapine is combined with Ramelteon.
Atazanavir
The serum concentration of Ramelteon can be increased when it is combined with Atazanavir.
Atomoxetine
The metabolism of Ramelteon can be decreased when combined with Atomoxetine.
Azelastine
Ramelteon may increase the central nervous system depressant (CNS depressant) activities of Azelastine.
Azithromycin
The metabolism of Ramelteon can be decreased when combined with Azithromycin.
Baclofen
The risk or severity of adverse effects can be increased when Baclofen is combined with Ramelteon.
Barbital
The risk or severity of adverse effects can be increased when Ramelteon is combined with Barbital.
Benoxinate
The risk or severity of adverse effects can be increased when Ramelteon is combined with Oxybuprocaine.
Benperidol
The risk or severity of adverse effects can be increased when Ramelteon is combined with Benperidol.
Benzocaine
The risk or severity of adverse effects can be increased when Ramelteon is combined with Benzocaine.
Benzyl Alcohol
The risk or severity of adverse effects can be increased when Ramelteon is combined with Benzyl alcohol.
Boceprevir
The serum concentration of Ramelteon can be increased when it is combined with Boceprevir.
Bortezomib
The metabolism of Ramelteon can be decreased when combined with Bortezomib.
Bosentan
The serum concentration of Ramelteon can be decreased when it is combined with Bosentan.
Bosentan Anhydrous
The serum concentration of Ramelteon can be decreased when it is combined with Bosentan.
Brexpiprazole
The risk or severity of adverse effects can be increased when Ramelteon is combined with Brexpiprazole.
Brimonidine
Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Ramelteon.
Bromazepam
The risk or severity of adverse effects can be increased when Bromazepam is combined with Ramelteon.
Bromperidol
The risk or severity of adverse effects can be increased when Ramelteon is combined with Bromperidol.
Brompheniramine
The risk or severity of adverse effects can be increased when Brompheniramine is combined with Ramelteon.
Brotizolam
The risk or severity of adverse effects can be increased when Ramelteon is combined with Brotizolam.
Bupivacaine
The risk or severity of adverse effects can be increased when Ramelteon is combined with Bupivacaine.
Buprenorphine
Ramelteon may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.
Buspirone
The risk or severity of adverse effects can be increased when Buspirone is combined with Ramelteon.
Butabarbital
The risk or severity of adverse effects can be increased when Butabarbital is combined with Ramelteon.
Butalbital
The risk or severity of adverse effects can be increased when Butalbital is combined with Ramelteon.
Butamben
The risk or severity of adverse effects can be increased when Ramelteon is combined with Butamben.
Butobarbital
The risk or severity of adverse effects can be increased when Ramelteon is combined with Butethal.
Butorphanol
The risk or severity of adverse effects can be increased when Butorphanol is combined with Ramelteon.
Caffeine
The metabolism of Ramelteon can be decreased when combined with Caffeine.
Capecitabine
The serum concentration of Ramelteon can be increased when it is combined with Capecitabine.
Carbamazepine
The metabolism of Ramelteon can be increased when combined with Carbamazepine.
Carbinoxamine
The risk or severity of adverse effects can be increased when Carbinoxamine is combined with Ramelteon.
Carisoprodol
The risk or severity of adverse effects can be increased when Carisoprodol is combined with Ramelteon.
Ceritinib
The serum concentration of Ramelteon can be increased when it is combined with Ceritinib.
Cetirizine
The risk or severity of adverse effects can be increased when Cetirizine is combined with Ramelteon.
Chloral Hydrate
The risk or severity of adverse effects can be increased when Ramelteon is combined with Chloral hydrate.
Chloramphenicol
The metabolism of Ramelteon can be decreased when combined with Chloramphenicol.
Chlordiazepoxide
The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Ramelteon.
Chlormethiazole
The risk or severity of adverse effects can be increased when Ramelteon is combined with clomethiazole.
Chlormezanone
The risk or severity of adverse effects can be increased when Ramelteon is combined with Chlormezanone.
Chloroprocaine
The risk or severity of adverse effects can be increased when Ramelteon is combined with Chloroprocaine.
Chlorpheniramine
The risk or severity of adverse effects can be increased when Ramelteon is combined with Chlorphenamine.
CHLORPHENIRAMINE POLISTIREX
The risk or severity of adverse effects can be increased when Ramelteon is combined with Chlorphenamine.
Chlorpromazine
The risk or severity of adverse effects can be increased when Chlorpromazine is combined with Ramelteon.
Chlorprothixene
The risk or severity of adverse effects can be increased when Ramelteon is combined with Chlorprothixene.
Chlorzoxazone
The risk or severity of adverse effects can be increased when Chlorzoxazone is combined with Ramelteon.
Cholecalciferol
The metabolism of Ramelteon can be decreased when combined with Cholecalciferol.
Cimetidine
The metabolism of Ramelteon can be decreased when combined with Cimetidine.
Citalopram
The metabolism of Ramelteon can be decreased when combined with Citalopram.
Clarithromycin
The serum concentration of Ramelteon can be increased when it is combined with Clarithromycin.
Clemastine
The metabolism of Ramelteon can be decreased when combined with Clemastine.
Clidinium
The risk or severity of adverse effects can be increased when Clidinium is combined with Ramelteon.
Clidinium bromide
The risk or severity of adverse effects can be increased when Clidinium is combined with Ramelteon.
Clobazam
The risk or severity of adverse effects can be increased when Clobazam is combined with Ramelteon.
Clomipramine
The risk or severity of adverse effects can be increased when Ramelteon is combined with Clomipramine.
Clonazepam
The risk or severity of adverse effects can be increased when Ramelteon is combined with Clonazepam.
Clonidine
The risk or severity of adverse effects can be increased when Clonidine is combined with Ramelteon.
Clorazepate
The risk or severity of adverse effects can be increased when Clorazepate is combined with Ramelteon.
CLORAZEPIC ACID
The risk or severity of adverse effects can be increased when Clorazepate is combined with Ramelteon.
Clotrimazole
The metabolism of Ramelteon can be decreased when combined with Clotrimazole.
Clozapine
The risk or severity of adverse effects can be increased when Clozapine is combined with Ramelteon.
Cobicistat
The serum concentration of Ramelteon can be increased when it is combined with Cobicistat.
Cocaine
The risk or severity of adverse effects can be increased when Ramelteon is combined with Cocaine.
Codeine
The risk or severity of adverse effects can be increased when Codeine is combined with Ramelteon.
Codeine Anhydrous
The risk or severity of adverse effects can be increased when Codeine is combined with Ramelteon.
CODEINE POLISTIREX
The risk or severity of adverse effects can be increased when Codeine is combined with Ramelteon.
Conivaptan
The serum concentration of Conivaptan can be increased when it is combined with Ramelteon.
Crizotinib
The metabolism of Ramelteon can be decreased when combined with Crizotinib.
Curcumin
The serum concentration of Ramelteon can be increased when it is combined with Curcumin.
Cyclizine
The risk or severity of adverse effects can be increased when Ramelteon is combined with Cyclizine.
Cyclobenzaprine
The risk or severity of adverse effects can be increased when Cyclobenzaprine is combined with Ramelteon.
Cyclosporine
The metabolism of Ramelteon can be decreased when combined with Cyclosporine.
Cyproheptadine
The risk or severity of adverse effects can be increased when Cyproheptadine is combined with Ramelteon.
Cyproterone Acetate
The serum concentration of Ramelteon can be decreased when it is combined with Cyproterone acetate.
Dabrafenib
The serum concentration of Ramelteon can be decreased when it is combined with Dabrafenib.
Dantrolene
The risk or severity of adverse effects can be increased when Ramelteon is combined with Dantrolene.
Dapiprazole
The risk or severity of adverse effects can be increased when Ramelteon is combined with Dapiprazole.
Darunavir
The serum concentration of Ramelteon can be increased when it is combined with Darunavir.
Dasatinib
The serum concentration of Ramelteon can be increased when it is combined with Dasatinib.
Dasatinib Anhydrous
The serum concentration of Ramelteon can be increased when it is combined with Dasatinib.
Deferasirox
The serum concentration of Ramelteon can be decreased when it is combined with Deferasirox.
Delavirdine
The serum concentration of Ramelteon can be increased when it is combined with Delavirdine.
Desflurane
The risk or severity of adverse effects can be increased when Desflurane is combined with Ramelteon.
Desipramine
The risk or severity of adverse effects can be increased when Ramelteon is combined with Desipramine.
Desloratadine
The risk or severity of adverse effects can be increased when Desloratadine is combined with Ramelteon.
Desvenlafaxine
The risk or severity of adverse effects can be increased when Ramelteon is combined with Desvenlafaxine.
Deutetrabenazine
The risk or severity of sedation and somnolence can be increased when Ramelteon is combined with Deutetrabenazine.
Dexbrompheniramine
The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with Ramelteon.
Dexmedetomidine
The risk or severity of adverse effects can be increased when Ramelteon is combined with Dexmedetomidine.
Dextromoramide
The risk or severity of adverse effects can be increased when Ramelteon is combined with Dextromoramide.
Dezocine
The risk or severity of adverse effects can be increased when Ramelteon is combined with Dezocine.
Diazepam
The risk or severity of adverse effects can be increased when Diazepam is combined with Ramelteon.
Dibucaine
The risk or severity of adverse effects can be increased when Ramelteon is combined with Cinchocaine.
Difenoxin
The risk or severity of adverse effects can be increased when Ramelteon is combined with Difenoxin.
Dihydrocodeine
The risk or severity of adverse effects can be increased when Dihydrocodeine is combined with Ramelteon.
Dihydroergotamine
The metabolism of Ramelteon can be decreased when combined with Dihydroergotamine.
Diltiazem
The metabolism of Ramelteon can be decreased when combined with Diltiazem.
Dimenhydrinate
The risk or severity of adverse effects can be increased when Ramelteon is combined with Dimenhydrinate.
Diphenhydramine
The risk or severity of adverse effects can be increased when Diphenhydramine is combined with Ramelteon.
Diphenoxylate
The risk or severity of adverse effects can be increased when Diphenoxylate is combined with Ramelteon.
Dothiepin
The serum concentration of Ramelteon can be increased when it is combined with Dosulepin.
Doxepin
The risk or severity of adverse effects can be increased when Ramelteon is combined with Doxepin.
Doxycycline
The metabolism of Ramelteon can be decreased when combined with Doxycycline.
Doxycycline Anhydrous
The metabolism of Ramelteon can be decreased when combined with Doxycycline.
Doxylamine
Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Ramelteon.
Dronedarone
The metabolism of Ramelteon can be decreased when combined with Dronedarone.
Droperidol
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Ramelteon.
Duloxetine
The risk or severity of adverse effects can be increased when Ramelteon is combined with Duloxetine.
Dyclonine
The risk or severity of adverse effects can be increased when Ramelteon is combined with Dyclonine.
Efavirenz
The metabolism of Ramelteon can be decreased when combined with Efavirenz.
Enflurane
The risk or severity of adverse effects can be increased when Ramelteon is combined with Enflurane.
Entacapone
The risk or severity of adverse effects can be increased when Entacapone is combined with Ramelteon.
Enzalutamide
The serum concentration of Ramelteon can be decreased when it is combined with Enzalutamide.
Erythromycin
The metabolism of Ramelteon can be decreased when combined with Erythromycin.
Escitalopram
The risk or severity of adverse effects can be increased when Ramelteon is combined with Escitalopram.
Eslicarbazepine Acetate
The metabolism of Ramelteon can be decreased when combined with Eslicarbazepine acetate.
Esomeprazole
The metabolism of Ramelteon can be decreased when combined with Esomeprazole.
Estazolam
The risk or severity of adverse effects can be increased when Estazolam is combined with Ramelteon.
Eszopiclone
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Ramelteon.
Ethanol
Ramelteon may increase the central nervous system depressant (CNS depressant) activities of Ethanol.
Ethchlorvynol
The risk or severity of adverse effects can be increased when Ramelteon is combined with Ethchlorvynol.
Ethosuximide
The risk or severity of adverse effects can be increased when Ethosuximide is combined with Ramelteon.
Ethotoin
The risk or severity of adverse effects can be increased when Ethotoin is combined with Ramelteon.
Ethyl Chloride
The risk or severity of adverse effects can be increased when Ramelteon is combined with Ethyl chloride.
Ethyl Loflazepate
The risk or severity of adverse effects can be increased when Ramelteon is combined with Ethyl loflazepate.
Ethylmorphine
The risk or severity of adverse effects can be increased when Ramelteon is combined with Ethylmorphine.
Etidocaine
The risk or severity of adverse effects can be increased when Ramelteon is combined with Etidocaine.
Etifoxine
The risk or severity of adverse effects can be increased when Ramelteon is combined with Etifoxine.
Etomidate
The risk or severity of adverse effects can be increased when Ramelteon is combined with Etomidate.
Etravirine
The metabolism of Ramelteon can be decreased when combined with Etravirine.
Ezogabine
The risk or severity of adverse effects can be increased when Ramelteon is combined with Ezogabine.
Felbamate
The risk or severity of adverse effects can be increased when Felbamate is combined with Ramelteon.
Fentanyl
The risk or severity of adverse effects can be increased when Fentanyl is combined with Ramelteon.
Fexofenadine
The risk or severity of adverse effects can be increased when Fexofenadine is combined with Ramelteon.
Flibanserin
The risk or severity of adverse effects can be increased when Ramelteon is combined with Flibanserin.
Floxuridine
The serum concentration of Ramelteon can be increased when it is combined with Floxuridine.
Fluconazole
The serum concentration of Ramelteon can be increased when it is combined with Fluconazole.
Flumazenil
Flumazenil may decrease the sedative activities of Ramelteon.
Flunarizine
The risk or severity of adverse effects can be increased when Ramelteon is combined with Flunarizine.
Flunitrazepam
The risk or severity of adverse effects can be increased when Ramelteon is combined with Flunitrazepam.
Fluorouracil
The serum concentration of Ramelteon can be increased when it is combined with Fluorouracil.
Fluoxetine
The metabolism of Ramelteon can be decreased when combined with Fluoxetine.
Flupenthixol
The risk or severity of adverse effects can be increased when Flupentixol is combined with Ramelteon.
Fluphenazine
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Ramelteon.
Flurazepam
The risk or severity of adverse effects can be increased when Flurazepam is combined with Ramelteon.
Fluspirilene
The risk or severity of adverse effects can be increased when Ramelteon is combined with Fluspirilene.
Fluticasone propionate
The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Ramelteon.
Fluvoxamine
The serum concentration of Ramelteon can be increased when it is combined with Fluvoxamine.
Fosamprenavir
The metabolism of Ramelteon can be decreased when combined with Fosamprenavir.
Fosaprepitant
The serum concentration of Ramelteon can be increased when it is combined with Fosaprepitant.
Fosphenytoin
The metabolism of Ramelteon can be increased when combined with Fosphenytoin.
Fospropofol
The risk or severity of adverse effects can be increased when Ramelteon is combined with Fospropofol.
Fusidate
The serum concentration of Ramelteon can be increased when it is combined with Fusidic Acid.
Fusidic Acid
The serum concentration of Ramelteon can be increased when it is combined with Fusidic Acid.
Gabapentin
The risk or severity of adverse effects can be increased when Gabapentin is combined with Ramelteon.
Gabapentin Enacarbil
The risk or severity of adverse effects can be increased when Ramelteon is combined with Gabapentin Enacarbil.
Gemfibrozil
The serum concentration of Ramelteon can be increased when it is combined with Gemfibrozil.
Glutethimide
The risk or severity of adverse effects can be increased when Ramelteon is combined with Glutethimide.
Guanfacine
The risk or severity of adverse effects can be increased when Ramelteon is combined with Guanfacine.
Halazepam
The risk or severity of adverse effects can be increased when Ramelteon is combined with Halazepam.
Haloperidol
The risk or severity of adverse effects can be increased when Haloperidol is combined with Ramelteon.
Halothane
The risk or severity of adverse effects can be increased when Ramelteon is combined with Halothane.
Heroin
The risk or severity of adverse effects can be increased when Ramelteon is combined with Heroin.
Hexobarbital
The risk or severity of adverse effects can be increased when Ramelteon is combined with Hexobarbital.
Hydrocodone
Ramelteon may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.
HYDROCODONE POLISTIREX
Ramelteon may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.
Hydromorphone
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Ramelteon.
Hydroxyzine
Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Ramelteon.
Hypoxis hemerocallidea root extract
The serum concentration of Ramelteon can be decreased when it is combined with St. John's Wort.
Idelalisib
The serum concentration of Ramelteon can be increased when it is combined with Idelalisib.
Iloperidone
The risk or severity of adverse effects can be increased when Ramelteon is combined with Iloperidone.
Imatinib
The metabolism of Ramelteon can be decreased when combined with Imatinib.
Imipramine
The risk or severity of adverse effects can be increased when Imipramine is combined with Ramelteon.
Indinavir
The serum concentration of Ramelteon can be increased when it is combined with Indinavir.
INDINAVIR ANHYDROUS
The serum concentration of Ramelteon can be increased when it is combined with Indinavir.
Isavuconazole
The serum concentration of Ramelteon can be increased when it is combined with Isavuconazole.
Isavuconazonium
The metabolism of Ramelteon can be decreased when combined with Isavuconazonium.
Isoflurane
The risk or severity of adverse effects can be increased when Isoflurane is combined with Ramelteon.
Isoniazid
The metabolism of Ramelteon can be decreased when combined with Isoniazid.
Isradipine
The metabolism of Ramelteon can be decreased when combined with Isradipine.
Itraconazole
The serum concentration of Ramelteon can be increased when it is combined with Itraconazole.
Ivacaftor
The serum concentration of Ramelteon can be increased when it is combined with Ivacaftor.
Ketamine
The risk or severity of adverse effects can be increased when Ketamine is combined with Ramelteon.
Ketazolam
The risk or severity of adverse effects can be increased when Ramelteon is combined with Ketazolam.
Ketoconazole
The serum concentration of Ramelteon can be increased when it is combined with Ketoconazole.
Lamotrigine
The risk or severity of adverse effects can be increased when Lamotrigine is combined with Ramelteon.
Levetiracetam
The risk or severity of adverse effects can be increased when Ramelteon is combined with Levetiracetam.
Levobupivacaine
The risk or severity of adverse effects can be increased when Ramelteon is combined with Levobupivacaine.
Levocabastine
The risk or severity of adverse effects can be increased when Ramelteon is combined with Levocabastine.
Levocetirizine
The risk or severity of adverse effects can be increased when Ramelteon is combined with Levocetirizine.
Levodopa
The risk or severity of adverse effects can be increased when Ramelteon is combined with Levodopa.
Levomethadyl
The risk or severity of adverse effects can be increased when Ramelteon is combined with Levomethadyl Acetate.
Levomilnacipran
The risk or severity of adverse effects can be increased when Ramelteon is combined with Levomilnacipran.
Levorphanol
The risk or severity of adverse effects can be increased when Levorphanol is combined with Ramelteon.
Lidocaine
The metabolism of Ramelteon can be decreased when combined with Lidocaine.
Lithium
The risk or severity of adverse effects can be increased when Ramelteon is combined with Lithium.
Lithium Cation
The risk or severity of adverse effects can be increased when Ramelteon is combined with Lithium.
Lofexidine
The therapeutic efficacy of Ramelteon can be increased when used in combination with Lofexidine.
Lopinavir
The serum concentration of Ramelteon can be increased when it is combined with Lopinavir.
Loratadine
The risk or severity of adverse effects can be increased when Loratadine is combined with Ramelteon.
Lorazepam
The risk or severity of adverse effects can be increased when Lorazepam is combined with Ramelteon.
Lormetazepam
The risk or severity of adverse effects can be increased when Ramelteon is combined with Lormetazepam.
Lovastatin
The metabolism of Ramelteon can be decreased when combined with Lovastatin.
Loxapine
The risk or severity of adverse effects can be increased when Loxapine is combined with Ramelteon.
Luliconazole
The serum concentration of Ramelteon can be increased when it is combined with Luliconazole.
Lumacaftor
The serum concentration of Ramelteon can be decreased when it is combined with Lumacaftor.
Lurasidone
The risk or severity of adverse effects can be increased when Lurasidone is combined with Ramelteon.
Magnesium Sulfate
The therapeutic efficacy of Ramelteon can be increased when used in combination with Magnesium sulfate.
MAGNESIUM SULFATE ANHYDROUS
The therapeutic efficacy of Ramelteon can be increased when used in combination with Magnesium sulfate.
Maprotiline
The risk or severity of adverse effects can be increased when Maprotiline is combined with Ramelteon.
Meclizine
The risk or severity of adverse effects can be increased when Meclizine is combined with Ramelteon.
Melatonin
The risk or severity of adverse effects can be increased when Ramelteon is combined with Melatonin.
Meperidine
The risk or severity of adverse effects can be increased when Pethidine is combined with Ramelteon.
Mephobarbital
The risk or severity of adverse effects can be increased when Ramelteon is combined with Methylphenobarbital.
Mepivacaine
The risk or severity of adverse effects can be increased when Ramelteon is combined with Mepivacaine.
Meprobamate
The risk or severity of adverse effects can be increased when Meprobamate is combined with Ramelteon.
Mesoridazine
The risk or severity of adverse effects can be increased when Ramelteon is combined with Mesoridazine.
Metaxalone
The risk or severity of adverse effects can be increased when Metaxalone is combined with Ramelteon.
Methadone
The risk or severity of adverse effects can be increased when Methadone is combined with Ramelteon.
Methadyl Acetate
The risk or severity of adverse effects can be increased when Ramelteon is combined with Methadyl Acetate.
Methapyrilene
The risk or severity of adverse effects can be increased when Ramelteon is combined with Methapyrilene.
Methaqualone
The risk or severity of adverse effects can be increased when Ramelteon is combined with Methaqualone.
Methocarbamol
The risk or severity of adverse effects can be increased when Methocarbamol is combined with Ramelteon.
Methohexital
The risk or severity of adverse effects can be increased when Methohexital is combined with Ramelteon.
Methotrimeprazine
Ramelteon may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine.
Methoxyflurane
The risk or severity of adverse effects can be increased when Ramelteon is combined with Methoxyflurane.
Methsuximide
The risk or severity of adverse effects can be increased when Ramelteon is combined with Methsuximide.
Metylperon
The risk or severity of adverse effects can be increased when Ramelteon is combined with Melperone.
Metyrosine
Ramelteon may increase the sedative activities of Metyrosine.
Mexiletine
The serum concentration of Ramelteon can be increased when it is combined with Mexiletine.
Midazolam
The risk or severity of adverse effects can be increased when Midazolam is combined with Ramelteon.
Midostaurin
The serum concentration of Ramelteon can be increased when it is combined with Midostaurin.
Mifepristone
The serum concentration of Ramelteon can be increased when it is combined with Mifepristone.
Milnacipran
The risk or severity of adverse effects can be increased when Ramelteon is combined with Milnacipran.
Minocycline
Minocycline may increase the central nervous system depressant (CNS depressant) activities of Ramelteon.
Mirtazapine
Ramelteon may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine.
Mitotane
The serum concentration of Ramelteon can be decreased when it is combined with Mitotane.
Moclobemide
The metabolism of Ramelteon can be decreased when combined with Moclobemide.
Modafinil
The metabolism of Ramelteon can be decreased when combined with Modafinil.
Molindone
The risk or severity of adverse effects can be increased when Ramelteon is combined with Molindone.
Morphine
The risk or severity of adverse effects can be increased when Morphine is combined with Ramelteon.
Nabilone
Nabilone may increase the central nervous system depressant (CNS depressant) activities of Ramelteon.
Nalbuphine
The risk or severity of adverse effects can be increased when Nalbuphine is combined with Ramelteon.
Nefazodone
The serum concentration of Ramelteon can be increased when it is combined with Nefazodone.
Nelfinavir
The serum concentration of Ramelteon can be increased when it is combined with Nelfinavir.
Netupitant
The serum concentration of Ramelteon can be increased when it is combined with Netupitant.
Nevirapine
The metabolism of Ramelteon can be increased when combined with Nevirapine.
Nicardipine
The serum concentration of Ramelteon can be increased when it is combined with Nicardipine.
Nilotinib
The metabolism of Ramelteon can be decreased when combined with Nilotinib.
Nitrazepam
The risk or severity of adverse effects can be increased when Nitrazepam is combined with Ramelteon.
Nitrous Oxide
The risk or severity of adverse effects can be increased when Nitrous oxide is combined with Ramelteon.
Nordazepam
The risk or severity of adverse effects can be increased when Ramelteon is combined with Nordazepam.
Norflurane
The risk or severity of adverse effects can be increased when Ramelteon is combined with Norflurane.
Normethadone
The risk or severity of adverse effects can be increased when Ramelteon is combined with Normethadone.
Nortriptyline
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Ramelteon.
Olanzapine
The risk or severity of adverse effects can be increased when Olanzapine is combined with Ramelteon.
Olaparib
The metabolism of Ramelteon can be decreased when combined with Olaparib.
Olopatadine
The risk or severity of adverse effects can be increased when Olopatadine is combined with Ramelteon.
Omeprazole
The metabolism of Ramelteon can be decreased when combined with Omeprazole.
Ondansetron
The risk or severity of adverse effects can be increased when Ramelteon is combined with Ondansetron.
Opium
The risk or severity of adverse effects can be increased when Ramelteon is combined with Opium.
Orphenadrine
Ramelteon may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.
Osimertinib
The serum concentration of Ramelteon can be increased when it is combined with Osimertinib.
Oxazepam
The risk or severity of adverse effects can be increased when Oxazepam is combined with Ramelteon.
Oxprenolol
The risk or severity of adverse effects can be increased when Ramelteon is combined with Oxprenolol.
Oxycodone
The risk or severity of adverse effects can be increased when Oxycodone is combined with Ramelteon.
Oxymorphone
The risk or severity of adverse effects can be increased when Oxymorphone is combined with Ramelteon.
Palbociclib
The serum concentration of Ramelteon can be increased when it is combined with Palbociclib.
Paliperidone
The risk or severity of adverse effects can be increased when Paliperidone is combined with Ramelteon.
Pantoprazole
The metabolism of Ramelteon can be decreased when combined with Pantoprazole.
Paraldehyde
Ramelteon may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.
Paregoric
The risk or severity of adverse effects can be increased when Morphine is combined with Ramelteon.
Paroxetine
The risk or severity of adverse effects can be increased when Ramelteon is combined with Paroxetine.
Peginterferon Alfa-2b
The serum concentration of Ramelteon can be increased when it is combined with Peginterferon alfa-2b.
Pentazocine
The risk or severity of adverse effects can be increased when Pentazocine is combined with Ramelteon.
Pentobarbital
The metabolism of Ramelteon can be increased when combined with Pentobarbital.
Perampanel
Perampanel may increase the central nervous system depressant (CNS depressant) activities of Ramelteon.
Perazine
The risk or severity of adverse effects can be increased when Ramelteon is combined with Perazine.
Perphenazine
The risk or severity of adverse effects can be increased when Perphenazine is combined with Ramelteon.
Phenobarbital
The metabolism of Ramelteon can be increased when combined with Phenobarbital.
Phenoxyethanol
The risk or severity of adverse effects can be increased when Ramelteon is combined with Phenoxyethanol.
Phenytoin
The metabolism of Ramelteon can be increased when combined with Phenytoin.
Pimozide
The risk or severity of adverse effects can be increased when Pimozide is combined with Ramelteon.
Pipamperone
The risk or severity of adverse effects can be increased when Ramelteon is combined with Pipamperone.
Pipothiazine
The risk or severity of adverse effects can be increased when Ramelteon is combined with Pipotiazine.
Pirinitramide
The risk or severity of adverse effects can be increased when Ramelteon is combined with Piritramide.
Pizotyline
The risk or severity of adverse effects can be increased when Ramelteon is combined with Pizotifen.
Pomalidomide
The risk or severity of adverse effects can be increased when Ramelteon is combined with Pomalidomide.
Posaconazole
The serum concentration of Ramelteon can be increased when it is combined with Posaconazole.
Pramipexole
Ramelteon may increase the sedative activities of Pramipexole.
Pramoxine
The risk or severity of adverse effects can be increased when Ramelteon is combined with Pramocaine.
Prazepam
The risk or severity of adverse effects can be increased when Ramelteon is combined with Prazepam.
Pregabalin
The therapeutic efficacy of Ramelteon can be increased when used in combination with Pregabalin.
Prilocaine
The risk or severity of adverse effects can be increased when Ramelteon is combined with Prilocaine.
Primidone
The metabolism of Ramelteon can be increased when combined with Primidone.
Procaine
The risk or severity of adverse effects can be increased when Ramelteon is combined with Procaine.
Prochlorperazine
The risk or severity of adverse effects can be increased when Prochlorperazine is combined with Ramelteon.
Promazine
The risk or severity of adverse effects can be increased when Promazine is combined with Ramelteon.
Promethazine
The risk or severity of adverse effects can be increased when Ramelteon is combined with Promethazine.
Proparacaine
The risk or severity of adverse effects can be increased when Ramelteon is combined with Proparacaine.
Propofol
The risk or severity of adverse effects can be increased when Propofol is combined with Ramelteon.
Propoxyphene
The risk or severity of adverse effects can be increased when Ramelteon is combined with Dextropropoxyphene.
Protriptyline
The risk or severity of adverse effects can be increased when Protriptyline is combined with Ramelteon.
Quazepam
The risk or severity of adverse effects can be increased when Quazepam is combined with Ramelteon.
Quetiapine
The risk or severity of adverse effects can be increased when Quetiapine is combined with Ramelteon.
Quetiapine fumarate
The risk or severity of adverse effects can be increased when Quetiapine is combined with Ramelteon.
Ranolazine
The metabolism of Ramelteon can be decreased when combined with Ranolazine.
Remifentanil
The risk or severity of adverse effects can be increased when Remifentanil is combined with Ramelteon.
Remoxipride
The risk or severity of adverse effects can be increased when Ramelteon is combined with Remoxipride.
Reserpine
The risk or severity of adverse effects can be increased when Reserpine is combined with Ramelteon.
Rifabutin
The metabolism of Ramelteon can be increased when combined with Rifabutin.
Rifampin
The metabolism of Ramelteon can be increased when combined with Rifampicin.
Rifapentine
The metabolism of Ramelteon can be increased when combined with Rifapentine.
Rifaximin
The metabolism of Ramelteon can be increased when combined with Rifaximin.
Risperidone
The risk or severity of adverse effects can be increased when Risperidone is combined with Ramelteon.
Ropinirole
Ramelteon may increase the sedative activities of Ropinirole.
Ropivacaine
The risk or severity of adverse effects can be increased when Ramelteon is combined with Ropivacaine.
Rotigotine
Ramelteon may increase the sedative activities of Rotigotine.
Rucaparib
The metabolism of Ramelteon can be decreased when combined with Rucaparib.
Rufinamide
The risk or severity of adverse effects can be increased when Rufinamide is combined with Ramelteon.
Saquinavir
The serum concentration of Ramelteon can be increased when it is combined with Saquinavir.
Saquinavir Mesylate
The serum concentration of Ramelteon can be increased when it is combined with Saquinavir.
Sarilumab
The therapeutic efficacy of Ramelteon can be decreased when used in combination with Sarilumab.
Scopolamine
The risk or severity of adverse effects can be increased when Scopolamine is combined with Ramelteon.
Scopolamine Hydrobromide
The risk or severity of adverse effects can be increased when Scopolamine is combined with Ramelteon.
Secobarbital
The risk or severity of adverse effects can be increased when Secobarbital is combined with Ramelteon.
Sertindole
The risk or severity of adverse effects can be increased when Ramelteon is combined with Sertindole.
Sertraline
The metabolism of Ramelteon can be decreased when combined with Sertraline.
Sevoflurane
The risk or severity of adverse effects can be increased when Sevoflurane is combined with Ramelteon.
Sildenafil
The metabolism of Ramelteon can be decreased when combined with Sildenafil.
Siltuximab
The serum concentration of Ramelteon can be decreased when it is combined with Siltuximab.
Simeprevir
The serum concentration of Ramelteon can be increased when it is combined with Simeprevir.
Sodium Oxybate
Ramelteon may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.
ST. JOHN'S WORT EXTRACT
The serum concentration of Ramelteon can be decreased when it is combined with St. John's Wort.
Sufentanil
The risk or severity of adverse effects can be increased when Sufentanil is combined with Ramelteon.
Sulfadiazine
The serum concentration of Ramelteon can be increased when it is combined with Sulfadiazine.
Sulfisoxazole
The serum concentration of Ramelteon can be increased when it is combined with Sulfisoxazole.
Sulpiride
The risk or severity of adverse effects can be increased when Ramelteon is combined with Sulpiride.
Suvorexant
Ramelteon may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.
Tapentadol
Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Ramelteon.
Tasimelteon
The risk or severity of adverse effects can be increased when Ramelteon is combined with Tasimelteon.
Telaprevir
The serum concentration of Ramelteon can be increased when it is combined with Telaprevir.
Telithromycin
The serum concentration of Ramelteon can be increased when it is combined with Telithromycin.
Temazepam
The risk or severity of adverse effects can be increased when Temazepam is combined with Ramelteon.
Tenofovir Disoproxil
The metabolism of Ramelteon can be decreased when combined with Tenofovir disoproxil.
Teriflunomide
The serum concentration of Ramelteon can be decreased when it is combined with Teriflunomide.
Tetrabenazine
The risk or severity of adverse effects can be increased when Ramelteon is combined with Tetrabenazine.
Tetracaine
The risk or severity of adverse effects can be increased when Ramelteon is combined with Tetracaine.
Tetracaine hydrochloride
The risk or severity of adverse effects can be increased when Ramelteon is combined with Tetracaine.
Tetrahydrocannabinol
Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Ramelteon.
Thalidomide
Ramelteon may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Theophylline
The metabolism of Ramelteon can be decreased when combined with Theophylline.
Theophylline anhydrous
The metabolism of Ramelteon can be decreased when combined with Theophylline.
Thiamylal
The risk or severity of adverse effects can be increased when Ramelteon is combined with Thiamylal.
Thiopental
The risk or severity of adverse effects can be increased when Ramelteon is combined with Thiopental.
Thiopental Sodium
The risk or severity of adverse effects can be increased when Ramelteon is combined with Thiopental.
Thioridazine
The risk or severity of adverse effects can be increased when Thioridazine is combined with Ramelteon.
Thiothixene
The risk or severity of adverse effects can be increased when Thiothixene is combined with Ramelteon.
Tiagabine
The risk or severity of adverse effects can be increased when Tiagabine is combined with Ramelteon.
Tiapride
The risk or severity of adverse effects can be increased when Ramelteon is combined with Tiapride.
Ticlopidine
The metabolism of Ramelteon can be decreased when combined with Ticlopidine.
Tizanidine
The risk or severity of adverse effects can be increased when Tizanidine is combined with Ramelteon.
Tocilizumab
The serum concentration of Ramelteon can be decreased when it is combined with Tocilizumab.
Tolbutamide
The serum concentration of Ramelteon can be increased when it is combined with Tolbutamide.
Tolcapone
The risk or severity of adverse effects can be increased when Tolcapone is combined with Ramelteon.
Topiramate
The metabolism of Ramelteon can be decreased when combined with Topiramate.
Tramadol
The risk or severity of adverse effects can be increased when Tramadol is combined with Ramelteon.
Tranylcypromine
The metabolism of Ramelteon can be decreased when combined with Tranylcypromine.
Trazodone
The risk or severity of adverse effects can be increased when Ramelteon is combined with Trazodone.
Triazolam
The risk or severity of adverse effects can be increased when Triazolam is combined with Ramelteon.
Triazulenone
The risk or severity of adverse effects can be increased when Ramelteon is combined with Loprazolam.
Trifluoperazine
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Ramelteon.
Triflupromazine
The risk or severity of adverse effects can be increased when Ramelteon is combined with Triflupromazine.
Trimipramine
The risk or severity of adverse effects can be increased when Trimipramine is combined with Ramelteon.
Triprolidine
The risk or severity of adverse effects can be increased when Triprolidine is combined with Ramelteon.
Urethane
The risk or severity of adverse effects can be increased when Ramelteon is combined with Ethyl carbamate.
Valproate
The risk or severity of adverse effects can be increased when Ramelteon is combined with Valproic Acid.
Valproic Acid
The risk or severity of adverse effects can be increased when Ramelteon is combined with Valproic Acid.
Vemurafenib
The serum concentration of Ramelteon can be increased when it is combined with Vemurafenib.
Venlafaxine
The metabolism of Ramelteon can be decreased when combined with Venlafaxine.
Verapamil
The metabolism of Ramelteon can be decreased when combined with Verapamil.
Vigabatrin
The risk or severity of adverse effects can be increased when Ramelteon is combined with Vigabatrin.
Voriconazole
The serum concentration of Ramelteon can be increased when it is combined with Voriconazole.
Vortioxetine
The risk or severity of adverse effects can be increased when Ramelteon is combined with Vortioxetine.
Xylazine
The risk or severity of adverse effects can be increased when Ramelteon is combined with Xylazine.
Zaleplon
The risk or severity of adverse effects can be increased when Zaleplon is combined with Ramelteon.
Ziconotide
The risk or severity of adverse effects can be increased when Ramelteon is combined with Ziconotide.
Ziprasidone
The metabolism of Ramelteon can be decreased when combined with Ziprasidone.
Zolpidem
Ramelteon may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.
Zonisamide
The risk or severity of adverse effects can be increased when Zonisamide is combined with Ramelteon.
Zopiclone
The risk or severity of adverse effects can be increased when Zopiclone is combined with Ramelteon.
Zotepine
The risk or severity of adverse effects can be increased when Ramelteon is combined with Zotepine.
Zuclopenthixol
The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with Ramelteon.
